Literature DB >> 1001616

Isolation and comparison of the proenzyme and activated forms of the human serum complement subcomponents C1r and C1s.

R B Sim, R R Porter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1001616     DOI： 10.1042/bst0040127

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  9 in total

1.  The unactivated form of the first component of human complement, C1.

Authors:  I Gigli; R R Porter; R B Sim
Journal:  Biochem J       Date:  1976-09-01       Impact factor: 3.857

2.  Inhibition of the reconstitution of the haemolytic activity of the first component of human complement by a pepsin-derived fragment of subcomponent C1q.

Authors:  K B Reid; R B Sim; A P Faiers
Journal:  Biochem J       Date:  1977-02-01       Impact factor: 3.857

3.  Structural features of the first component of human complement, C1, as revealed by surface iodination.

Authors:  C L Villiers; S Chesne; M B Lacroix; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

4.  C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes.

Authors:  R B Sim; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1979-06-01       Impact factor: 3.857

5.  The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement.

Authors:  R B Sim; R R Porter; K B Reid; I Gigli
Journal:  Biochem J       Date:  1977-05-01       Impact factor: 3.857

6.  The purification and characterization of subcomponent C1s of the first component of bovine complement.

Authors:  R D Campbell; N A Booth; J E Fothergill
Journal:  Biochem J       Date:  1979-12-01       Impact factor: 3.857

7.  Human complement component C4. Structural studies on the fragments derived from C4b by cleavage with C3b inactivator.

Authors:  E M Press; J Gagnon
Journal:  Biochem J       Date:  1981-11-01       Impact factor: 3.857

8.  The catalytic chain of human complement subcomponent C1r. Purification and N-terminal amino acid sequences of the major cyanogen bromide-cleavage fragments.

Authors:  G J Arlaud; J Gagnon; R R Porter
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

9.  The serine proteinase chain of human complement component C1s. Cyanogen bromide cleavage and N-terminal sequences of the fragments.

Authors:  P E Carter; B Dunbar; J E Fothergill
Journal:  Biochem J       Date:  1983-12-01       Impact factor: 3.857
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.